Skip to main content
. 2019 Jun 12;9:8531. doi: 10.1038/s41598-019-44630-4

Table 1.

Infection and treatment schedule in BALB/c mice.

Infection development treatment & sacrificed Treatment Group – I (Control) Treatment Group – II Vit. D3/RA Treatment Group – III CDCA/RA
Infection development for 21 days 2 × 107 promastigotes (i.v.) 2 × 107 promastigotes (i.v.) 2 × 107 promastigotes (i.v.)
Day 7 (P.I.) PBS (100 µl)

Oral Vit. D3/RA

384 ng/30 ng/kg

Oral CDCA/RA

78 ng /30 ng/kg
Day 14 (P.I.) PBS (100 µl)

Oral Vit. D3/RA

384 ng/30 ng/kg

Oral CDCA/RA

78 ng /30 ng/kg
Day 21 (P.I.) PBS (100 µl)

Oral Vit. D3/RA

384 ng/30 ng/kg

Oral CDCA/RA

78 ng /30 ng/kg
Day 28 (P.I.) PBS (100 µl)

Oral Vit. D3/RA

384 ng /30 ng/kg

Oral CDCA/RA

78 ng /30 ng/kg